Home
>
National Drug Code (NDC)
>
BOSULIF
BOSULIF - 0069-0135-01 - (Bosutinib monohydrate)
Drug Information of BOSULIF
| Product NDC: | 0069-0135 |
| Proprietary Name: | BOSULIF |
| Non Proprietary Name: | Bosutinib monohydrate |
| Active Ingredient(s): | 100 mg/1 & nbsp; Bosutinib monohydrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BOSULIF
| Product NDC: | 0069-0135 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203341 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120904 |
Package Information of BOSULIF
| Package NDC: | 0069-0135-01 |
| Package Description: | 120 TABLET, FILM COATED in 1 BOTTLE (0069-0135-01) |
NDC Information of BOSULIF
| NDC Code | 0069-0135-01 |
| Proprietary Name | BOSULIF |
| Package Description | 120 TABLET, FILM COATED in 1 BOTTLE (0069-0135-01) |
| Product NDC | 0069-0135 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bosutinib monohydrate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120904 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | BOSUTINIB MONOHYDRATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
